**INTRODUCTION:** Paradoxical adipose hyperplasia (PAH) is a rare complication of cryolipolysis, the most commonly used non-surgical fat reduction technique in the world. PAH is diagnosed when the treated area enlarges over a few months after treatment rather than showing reduction in subcutaneous fat. In this study, we report our experience with 11 patients seen in our office with a diagnosis of PAH over the past 3 years. Their clinical presentation, management, and corrective treatment options are reviewed.

**METHODS:** This is a retrospective review of 11 patients with PAH following cryolipolysis. The treatment parameters, demographics, onset of findings, and subsequent treatment were chronicled.

**RESULTS:** All eleven cases of PAH (8 males, 3 females) were of Hispanic background. The average age was 42.5 years and the mean body mass index was 26.7 kg/m2. These patients presented with a painless, enlarged area of subcutaneous tissue at the treatment site, which occurred on average at 2.85 months following cryolipolysis. Nine cases occurred in the abdomen, seven of which were originally treated using the large cryolipolysis applicator. Four patients were first-degree relatives with similar clinical presentations. Of the 11 patients with PAH, five patients were subsequently treated with liposuction and one was treated with a combination of liposuction and an abdominoplasty, achieving both good cosmetic results and patient satisfaction. Our incidence of 0.38% (8 PAH events in 2073 treatment cycles) was significantly higher than the incidence reported by the manufacturer (0.025%).

**CONCLUSION:** Despite following appropriate treatment guidelines, our PAH incidence shows a 15-fold increase when compared to that reported by the manufacturer. We believe PAH is an underreported clinical entity of significant burden to the patients. Hispanic, middle-aged men undergoing cryolipolysis of the abdomen with a large applicator seem to be at increased risk for developing PAH. Further studies are needed to define the role of genetics, androgens, and other potential risk factors for PAH. Liposuction and/or abdominoplasty at the appropriate time after diagnosis, are helpful in treating this problem.
